ACE inhibitors after myocardial infarction
ACE inhibitors after myocardial infarction
Medical devices
Familial dilated cardiomyopathy in the United Kingdom
Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction
Placebo controlled trial of felodipine in patients with mild to moderate heart failure
Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril
Change in delay of atrioventricular conduction after radiofrequency catheter ablation for atrioventricular nodal re-entry tachycardia
Ventilatory responses to exercise in adults after repair of tetralogy of Fallot
Effects of type 1 diabetes mellitus on cardiac function
Surgery for infants with a hypoplastic systemic ventricle and severe outflow obstruction
High wall shear stress proximal to myocardial bridging and atherosclerosis
Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction?
ACE for whom? Implications for clinical practice of post-infarct trials
Permanent pacemaker practice at a Scottish district general hospital between 1987 and 1993
Combined atrial and arterial switch procedure for congenital corrected transposition with ventricular septal defect
Systemic thromboembolism leading to myocardial infarction and stroke after fenestrated total cavopulmonary connection
Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy
Nocturnal hypoxaemia after myocardial infarction
Nocturnal hypoxaemia after myocardial infarction
Increase in plasma beta endorphins precedes vasodepressor syncope
Increase in plasma beta endorphins precedes vasodepressor syncope